Wang XQ, Liu Z, Lv WP, Luo Y, Yang GY, Li CH, Meng XF, Liu Y, Xu KS, Dong JH. Safety validation of decision trees for hepatocellular carcinoma. World J Gastroenterol 2015; 21(31): 9394-9402 [PMID: 26309366 DOI: 10.3748/wjg.v21.i31.9394]
Corresponding Author of This Article
Jia-Hong Dong, MD, PhD, FACS, Department of Hepatobiliary Surgery, PLA General Hospital, No. 28 Fuxing Road, Beijing 100853, China. dongjh_301@163.com
Research Domain of This Article
Gastroenterology & Hepatology
Article-Type of This Article
Retrospective Study
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Gastroenterol. Aug 21, 2015; 21(31): 9394-9402 Published online Aug 21, 2015. doi: 10.3748/wjg.v21.i31.9394
Table 1 Basic information on the study population
Factors
n (%)
Age (yr), mean (SD)
51.8 (12.4)
Age > 65 yr
102 (15.1)
Male
502 (79.2)
ICG R15
< 10%
545 (86.8)
10%-20%
69 (10.9)
20%-30%
8 (1.3)
30%-40%
6 (0.9)
> 40%
6 (0.9)
Hepatitis serology
Hepatitis B
452 (71.3)
Hepatitis C
34 (5.4)
Hepatitis B and C
25 (3.9)
Negative or not determined
123 (19.4)
Cirrhosis
479 (75.5)
Portal vein hypertention
78 (12.3)
Table 2 Preoperative biochemical indices and ratings n (%)
Serum albumin (g/L)
41.1 (4.0)
Platelet count (103/mm3)
178.6 (75.1)
Serum creatinine (μmol/L)
67.7 (14.0)
Serum total bilirubin (μmol/L)
Serum total bilirubin (μmol/L)
6.3 (14.2)
Serum sodium (mmol/L)
142.0 (2.8)
INR, mean (SD)
1.04 (0.10)
CTP score
Class A
629 (98.2)
Class B
5 (0.8)
MELD score, mean (SD)
8.4 (1.5)
Tumor size (cm)
7.4 (4.9)
Table 3 Relevant surgical indices n (%)
Operating time (min)
251 (52)
Porta hepatis clamping time (min)
20 (11.2)
Estimated blood loss (mL)
438 (559.7)
Extent of hepatectomy
Subsegmentectomy or limited resection
262 (41.3)
Segmentectomy
163 (5.7)
Bisegmentectomy
90 (14.2)
Major hepatectomy (3 or more segments)
119 (18.8)
Intraoperative RBC transfusion
Yes
142 (22.4)
No
492 (77.6)
Blocking methods
Portal vein blocking
30 (4.7)
Pringle maneuver
392 (61.8)
No
212 (33.4)
Table 4 Postoperative complications of hepatectomy
Overall morbidity
44.90%
Surgical morbidity
Posthepatectomy liver failure
19%
Biliary leakage
40%
Posthepatectomy hemorrhage
7%
Perihepatic abscess
22%
Wound infection
42%
Cholangitis
5%
Pleural effusion
62%
Portal vein thrombosis
3%
Medical morbidity
Respiratory insufficiency/failure
12%
Renal failure
6%
Pneumonia
28%
Cardiac arrhythmia
20%
Pulmonary embolism
2%
Cardiac failure
8%
Myocardial infarction
5%
Relaparotomy
4%
Table 5 Postoperative liver failure rate according to criteria
Criteria
Yes
No
Swiss
2.75%
5.66%
Japan
2.62%
6.56%
Chinese
2.73%
16.67%
Table 6 Multivariate logistic analysis of hepatic failure
Variables in the equation
Sig.
Liver cirrhosis
0.009
Bile leakage
0.199
Ascites
0.184
Abdominal infection
0.014
Major hepatectomy
0.006
Bleeding
0.878
Height (cm)
0.710
Weight (kg)
0.361
HB (g/dL)
0.819
BSA (m2)
0.384
BMI (kg/m2)
0.733
Kmin
0.356
ICGR15
0.510
T12 (min)
0.617
EHBF (L/min)
0.472
Total hospital duration
0.017
Citation: Wang XQ, Liu Z, Lv WP, Luo Y, Yang GY, Li CH, Meng XF, Liu Y, Xu KS, Dong JH. Safety validation of decision trees for hepatocellular carcinoma. World J Gastroenterol 2015; 21(31): 9394-9402